Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and acceptability of oral Truvada vs rectal tenofovir gel for HIV prevention
NCT01687218Phase 2Completed
- Sponsor
- CONRAD
- Start
- Sep 2013
- Primary completion
- May 2015
- Modality
- Implantable Devices, Transdermal Patches, Hydrogel Systems
- Countries
- 5
01
Overview
A Phase 2 trial of tenofovir gel in human immunodeficiency virus infection (HIV), sponsored by CONRAD. Started Sep 2013; status: completed.
02
Drugs
tenofovir gel
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01687218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01687218.